Stories
Medicaid clients and members rate Prime’s performance
We asked, and they told us how we’re doing. And it’s very good news.
September 24, 2019When our clients are satisfied, so are we
Our Medicaid clients specifically showed high satisfaction with Prime’s reporting, flexibility and our client engagement/account teams. Prime scored 100 percent in these areas:
- Resolving problems in a timely manner
- Member marketing communication and collateral (electronic and print)
- Delivery of training or information on new products and services
- Network pricing and strategy
Prime is pleased to report these high client satisfaction and high member satisfaction scores. Our most recent survey showed that 92 percent of our clients’ Medicaid members reported being “satisfied” or “very satisfied” with their prescription drug plan. For Prime, this is extremely good news, because we always put members first. It’s part of our purpose. It’s how we work with Blue Plans to make health care better.
Medicaid programming is an essential part of what a health plan offers its community. Diversity of a population’s needs, as well as regulatory oversight, demand a unique market-specific focus. Prime understands that this unique market requires a dedicated team. Prime’s Medicaid team really understands this market. We collaborate with our clients to find solutions that balance low cost and quality outcomes. This approach drives our success, providing value that benefits our clients and members.
Related news
Stories
April 24, 2024
New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care
Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances
Stories
April 5, 2024
LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast
In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.
Stories
March 26, 2024
Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits
Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report…